Silo Pharma Engages Clarivate For Intellectual Property And Patent Management
Portfolio Pulse from Benzinga Newsdesk
Silo Pharma has engaged Clarivate for the management of its expanding intellectual property and patent portfolio. Clarivate will monitor, manage, and maintain the company's IP assets.
August 10, 2023 | 12:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Silo Pharma's partnership with Clarivate for IP and patent management could potentially strengthen its position by ensuring the protection and maintenance of its IP assets.
Intellectual property is a key asset for pharmaceutical companies. By engaging Clarivate, a leader in IP management, Silo Pharma is taking steps to protect and manage its IP assets. This could potentially strengthen its position in the market and positively impact its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100